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Members of the Src family of kinases (SFKs) are non-receptor tyrosine kinases involved in
numerous signal transduction pathways.The catalytic, SH3 and SH2 domains are attached
to the membrane-anchoring SH4 domain through the intrinsically disordered “Unique”
domains, which exhibit strong sequence divergence among SFK members. In the last
decade, structural and biochemical studies have begun to uncover the crucial role of
the Unique domain in the regulation of SFK activity. This mini-review discusses what
is known about the phosphorylation events taking place on the SFK Unique domains,
and their biological relevance. The modulation by phosphorylation of biologically relevant
inter- and intra- molecular interactions of Src, as well as the existence of complex
phosphorylation/dephosphorylation patterns observed for the Unique domain of Src,
reinforces the important functional role of the Unique domain in the regulationmechanisms
of the Src kinases and, in a wider context, of intrinsically disordered regions in cellular
processes.
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INTRODUCTION
The Src kinase family is composed of 10 proteins: Src, Frk,
Lck, Lyn, Blk, Hck, Fyn, Yrk, Fgr, and Yes. Src family kinases
(SFKs) are membrane-associated, non-receptor tyrosine kinases
that act as important signaling intermediaries regulating a variety
of outputs, such as cell proliferation, differentiation, apop-
tosis, migration, and metabolism. All SFKs share the same
domain arrangement: a large catalytic C-terminal domain is
preceded by regulatory Src 2 and 3 homology domains (SH2
and SH3, respectively) and the membrane-anchoring SH4 N-
terminal region, which contain myristoylation and palmitoylation
sites as well as positively charged residues. The SH3 and SH4
domains are linked by an intrinsically disordered segment of
50–90 residues, called the Unique domain (UD) because of the
lack of sequence similarity among the different SFKs. How-
ever, the UD of each individual SFK member is well conserved
between different organisms suggesting a more speciﬁc role
than that of a simple spacer. Figure 1 shows the sequences of
the UDs of the 10 SFKs, highlighting known phosphorylation
sites.
Efforts to ﬁnd speciﬁcUD functions during the last two decades
have conﬁrmed an active role of the UD in the regulation of SFK
members. In the case of Lck, the UD mediates association with
the cytoplasmic tail of CD4 and CD8α through a zinc clasp struc-
ture (Kim et al., 2003). For most of the other SFK members the
detailedmechanisms remain obscure. TheUnique domains of Fyn
and Lynwere observed to be cleaved during induction of apoptosis
in intact hematopoietic cells, revealing a novel mechanism for the
speciﬁc regulation of different SFKs, with important consequences
for their cellular localization and activity (Luciano et al., 2001).
Several SFKs contain residues in the N-terminal region that are
phosphorylated anddephosphorylated in cellular processes (Joung
et al., 1995; Hansen et al., 1997; Johnson et al., 2000). Moreover,
swapping the Unique domains of Src and Yes interchanges the
functional speciﬁcity of the two SFKs (Hoey et al., 2000; Summy
et al., 2003; Werdich and Penn, 2005). The versatility and rele-
vance of the active role of the Unique domain in Src function
was conﬁrmed by the discovery of binding by the Unique domain
to different targets, such as acidic lipids, the SH3 domain, and
calmodulin (Pérez et al., 2013). The amino-acid sequence of the
UD region responsible for some of these interactions is conserved
in Src, Fyn, and Yes. The three proteins are co-expressed in many
tissues and are partially redundant, in the sense that deﬁciency
in one of them can be compensated by the action of the other
two.
The involvement of SFK signaling in growth, motility and cell
survival makes them important oncology targets. Activation of
SFKs is tightly regulated in healthy cells (Boggon and Eck, 2004),
while the kinase activation is often deregulated in cancer, giving
rise to altered cellular shape, function, and growth (Vlahovic and
Crawford, 2003). Among the SFKs, Src is the most studied and
the most commonly discussed in the context of cancer (Yeatman,
2004). However, there has been growing interest in the other SFKs
in both normal physiological and pathological states.
The UD is an intrinsically disordered region (IDR). Intrin-
sically disordered proteins (IDPs) are relatively more prevalent
among signaling and cancer-related proteins (Iakoucheva et al.,
2002). The connection between disorder and diseases such as
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FIGURE 1 | Phosphorylation and lipid binding sites in the Unique
domain of SFK. Alignment of the UD sequences of the ten SFK. The
alignment has been manually edited to emphasize the similarities in
regions that are known to be functionally relevant in at least one SFK
member. Residues highlighted in green are identiﬁed as phosphorylation
sites in PhosphoSitePlus (Hornbeck et al., 2012). Conservation of
phosphorylation sites was used as a reference in the alignment
presented.
cancer, neurodegenerative conditions, amyloidosis, cardiovascu-
lar disease, and diabetes has been extensively explored in recent
reviews (Uversky et al., 2008; Uros et al., 2009). Diseases arising
from structural changes in proteins, loosely grouped as “confor-
mational diseases” are caused not only by protein misfolding, but
also by failures in post-translational modiﬁcations that result in
aberrant interactions with physiological partners (Uversky et al.,
2008). Remarkably, mutations in disordered regions can result in
the loss of important post-translational modiﬁcation sites, leading
to disease (Li et al., 2010). The recognition of the crucial role of
IDPs in a number of diseases has heralded a new era in the design
of drugs (Chen et al., 2006).
While the catalytic and Src homology domains of SFKs have
long been subjects of investigation, the study of the regula-
tory mechanisms involving the intrinsically disordered UD has
only recently started gaining momentum. Phosphorylation events
are often associated with the regulation of important functional
regions. In this mini-review we discuss the current knowledge
about the phosphorylation events taking place in the Unique
domains of SFKs.
PHOSPHORYLATION OF THE UNIQUE DOMAIN OF Lck
The Unique domain linking the SH4 and the SH3 domain of Lck
is one of the smallest of the family, with only 60 amino acids. Dur-
ing T-cell activation, Ser59 in the Unique N-terminal region of
Lck is phosphorylated (Watts et al., 1993;Winkler et al., 1993). The
Unique domain of Lck contains a proline-rich region surrounding
Ser59 (56PPASP60). Joung et al. (1995) found thatmodiﬁcations of
Ser59 in theUniqueN-terminal domain of tyrosine kinase Lck reg-
ulate speciﬁcity of its SH2 domain. Later on, Ser59 was identiﬁed
as a site of in vivo mitotic phosphorylation in Lck (Kesavan et al.,
2002). More recently, a new target was found for Lck: the protein
Nck (Vázquez, 2007), consisting of one SH2 domain and three
SH3 domains, which is known to link receptor tyrosine kinases
to downstream proteins, and to be active in actin polymerization.
It was also reported that Nck binds in T cells to the CD3 subunit
of the T-cell antigen receptor (TCR) following TCR engagement.
Interestingly, the inter-molecular interaction between Lck and
Nck was observed to be disrupted by phosphorylation at Ser59
within the Unique domain of Lck. Wild-type Lck (wt-Lck) and
a Ser59Asp-Lck mutant transfected into Lck-deﬁcient JCaM1.6
cells showed differences in the activation of proximal versus distal
signaling events (Vázquez, 2007).
PHOSPHORYLATION OF THE UNIQUE DOMAIN OF Hck
Hematopoietic cell kinase (Hck) is a potential drug target for can-
cer and HIV infections. High levels of Hck are associated with
drug resistance in chronic myeloid leukemia and Hck activity has
been connected with HIV-1 (Tintori et al., 2013). An important
insight into the activation mechanism of this SFK member was
the discovery that Hck is capable of performing autophosphoryla-
tion in its UD. Autophosphorylation of the activation loop in the
kinase domain is a common process for SFK activation. Autophos-
phorylation of recombinant Hck leads to a 20-fold increase in its
speciﬁc enzymatic activity (Johnson et al., 2000). Hck was found
to autophosphorylate readily to a stoichiometry of 1.3 mol of
phosphate permol of enzyme, indicating that the kinase autophos-
phorylated at more than one site. In particular, Johnson and
collaborators discovered — in vitro as well as in vivo—that Hck
can undergo autophosphorylation at two different sites: Tyr388,
which is located at the consensus autophosphorylation site in the
well-characterized activation loop of similar kinases, and Tyr29,
which is located in its intrinsically disordered Unique domain. By
inspecting the activities and levels of phosphorylation of recombi-
nantHckmutants containing either the pointmutationTyr388Phe
or Tyr29Phe, they demonstrated that phosphorylation at Tyr29
makes a crucial contribution to the activation of Hck through its
autophosphorylation. Regulation of the catalytic activity by phos-
phorylation at Tyr29 in the Unique domain of Hck suggests that
autophosphorylation within the N-terminal Unique region may
also be an additional mechanism of regulation of other Src family
tyrosine kinases.
TYROSINE PHOSPHORYLATION IN OTHER UNIQUE
DOMAINS: Lyn, Yes, Fgr, AND Frk
Interestingly, the tyrosine residue in position 32 of Lyn is located
in an 8-residue-long sequence common to Lyn and Hck. EGFR
phosphorylates the p56 isoform of Lyn, p56Lyn, at Tyr32, which
then phosphorylates MCM7, a licensing factor critical for DNA
replication. Phosphorylation at Tyr600 of MCM7 increases its
association with other minichromosome maintenance complex
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proteins, thereby promoting DNA synthesis complex assembly
and cell proliferation. Both p56Lyn Tyr32 andMCM7Tyr600 phos-
phorylation are enhanced in proliferating cells and correlated with
poor survival of breast cancer patients (Huang et al., 2013).
All Unique domains contain aromatic residues, a rare feature
in intrinsically disordered domains. A tyrosine residue is present
between positions 25 and 34 in seven SFKs, and is known to
be phosphorylated in ﬁve of them: Lyn, Hck, Lck (Hornbeck
et al., 2012), Yes (Ariki et al., 1997), and Frg (Oppermann et al.,
2009). Phosphorylation of Tyr34 of Fgr has been observed my
mass spectrometry mainly in samples from leukemia patients.
Frk is the only SFK that is not myristoylated. Although it
contains three tyrosine residues in its Unique domain, phospho-
rylation has only been reported for Tyr46, at the interface between
the Unique and SH3 domains. The modiﬁcation was observed by
mass spectrometry mainly in samples from lung, liver, and gastric
cancer (Stokes et al., 2012).
PHOSPHORYLATION OF THE UNIQUE DOMAIN OF Fyn
Fyn is ubiquitously expressed together with Src and Yes, whereas
other members of the Src family are expressed only in speciﬁc cell
types. Fyn is primarily localized to the cytoplasmic leaﬂet of the
plasma membrane, where it phosphorylates tyrosine residues on
key targets involved in a variety of different signaling pathways.
Fyn characterization has been mainly focused on its immune and
neurological function. However, Fyn has also been recognized
as an important mediator of mitogenic signaling and regulator
of cell-cycle entry, growth, and proliferation, integrin-mediated
interactions as well as cell adhesion and migration (Kawakami
et al., 1988; Chen et al., 2001; Li et al., 2003; Kim et al., 2010).
In particular, Fyn is over-expressed in several cancers, such as
glioblastoma multiformae and melanoma. The role of Fyn over-
expression in these systems, however, has not been well deﬁned
as yet.
Fyn presents multiple phosphorylation sites that can affect
its kinase activity. Activation of Platelet-Derived Growth Fac-
tor (PDGF) β-receptor by binding to PDGF leads to activation
of a member of the SFK (Alonso et al., 1995). The Unique
domain of Fyn was found to be phosphorylated at Tyr28 (Hansen
et al., 1997). The functional role of this phosphorylation was
conﬁrmed by the observation of signiﬁcantly reduced activa-
tion following PDGF stimulation of a Fyn mutant in which
Tyr28 was replaced by phenylalanine (Hansen et al., 1997). It was
also proposed that the autophosphorylation of the N-terminal
tyrosine residues plays a key role in the activation of Fyn, by
complementing the PDGF receptor-induced phosphorylation of
Tyr28.
Serine 21 within the UD of Fyn is part of a RxxS motif tar-
geted by protein kinase A (PKA). Mutation of Ser21 to Alanine
(Ser21Ala-Fyn) blocks PKA phosphorylation of Fyn and alters its
tyrosine kinase activity (Yeo et al., 2011). In the same work, the
authors showed that the over-expression of Ser21Ala-Fyn mutant
in cells lacking Src/Yes/Fyn kinases (SYF cells) led to decreased
tyrosine phosphorylation of focal adhesion kinase, resulting in
reduced focal adhesion targeting, and slow lamellipodia dynam-
ics and cell migration. These important changes in cell motility
demonstrate a key role of UD phosphorylation at Ser21 in the Fyn
kinase activity that controls assembly and disassembly of focal
adhesions in response to signals arising from cell-extracellular
matrix interactions.
Protein kinase A is a crucial component of integrin-mediated
signaling pathways. Interaction of cells with their substrate or
adhesion to other cells leads to activation of PKA (Whittard and
Akiyama, 2001), and induce the phosphorylation of a variety of
protein substrates (Walsh and Van Patten, 1994). Four SFKs (Fyn,
Src, Lck, and Fgr) contain a conserved RxxS motif suggesting they
can be regulated by PKA.
PHOSPHORYLATION OF THE UNIQUE DOMAIN OF Src
Src is a non-receptor protein tyrosine kinasewith a key role in regu-
lating cell-to-matrix adhesion, migration, and junctional stability
(Frame, 2004). Thus, precise regulation of Src activity is criti-
cal for normal cell growth. The inactive state of Src is obtained
by phosphorylated tyrosine near the C-terminus of Src (Tyr530
in mammalian Src; Tyr527 in chicken Src), which is recognized
by its SH2 domain, while the SH3 domain interacts with a poly-
proline motif located in the linker region between the SH2 and
kinase domains; these intramolecular interactions restrict access
to the kinase domain (Xu et al., 1997). Dephosphorylation of
Tyr530 is followed by autophosphorylation at Tyr419, leading
to full activation of the kinase. Active Src may be deactivated
by rephosphorylation of Tyr530 by C-terminal Src kinase (Csk;
Piwnica-Worms et al., 1987; Nada et al., 1991; Brown, 1996).
Although the phosphorylation of Src at Ser17 by PKA
(cAMP-dependent protein kinase) is a well-characterized pro-
cess, its biological signiﬁcance remains unclear (Obara et al.,
2004). Potential roles in protein–protein interactions or cellu-
lar localization have been postulated for this phosphorylation
site. For instance, it has been observed that the treatment
of 3T3 ﬁbroblasts with PDGF results in the translocation of
Src from the plasma membrane to the cytosol, concomitant
with an increase in phosphorylation of Ser17 by PKA (Walker
et al., 1993). This observation suggests that this phosphoryla-
tion could interfere with the electrostatic interactions that act
to anchor Src to the lipid bilayer. PKA phosphorylation of Src
at Ser17 is also required in cAMP activation of Rap1, inhibi-
tion of extracellular signal-regulated kinases, and inhibition of
cell growth, although the mechanism by which this phospho-
rylation mediates these processes is not known (Obara et al.,
2004).
Interaction of Src with lipids is not restricted to the SH4
domain (Figure 2). The unique lipid binding region (ULBR)
was discovered following NMR observations that revealed a par-
tially structured region within the UD of Src (Pérez et al., 2009).
While phosphorylation of Ser17 by PKA disturbed the interaction
of the SH4 domain with lipids, phosphorylation of Thr37 and
Ser75 by p25-Cdk5 decreased lipid binding by the ULBR (Pérez
et al., 2009). Cross-effects were observed, suggesting a coopera-
tive interaction of the two lipid binding regions with membranes.
Conformational effects of phosphorylation at Ser17, Thr37, and
Ser75 in the isolated UD are strictly local, indicating that electro-
static repulsion of the phosphorylated residues with the negatively
charged lipids is the main mechanism by which lipid binding is
disrupted.
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FIGURE 2 | Phosphorylation sites in the UD of Src and their
relationship with the two lipid-binding regions: the classical SH4
domain and the ULBR.
The ULBR major regulatory role of the UD was shown exper-
imentally in Xenopus laevis oocytes. Mutations abolishing lipid
binding by the ULBR but not affecting the SH4 domain resulted
in a conditional lethal phenotype after progesterone induced
maturation (Pérez et al., 2013).
Previous results had identiﬁed a functional role for Thr37
and Ser75 (Thr34 and Ser72 in chicken Src) as well as Thr46 in
chicken Src (with no correspondence in humans). These residues
are phosphorylated by cyclin-dependent kinase 1 (Cdk1/Cdc2)
during mitosis. These phosphorylations were found to activate
Src by disrupting the interaction between the SH2 domain and
Tyr527/Tyr530 (chicken/human) and facilitating the dephospho-
rylation by protein tyrosine phosphatases (Shenoy et al., 1992;
Stover et al., 1994).
In addition (or possibly related to) its effect on lipid bind-
ing, phosphorylation of Ser75 is important in other aspects of
Src regulation. Mitosis-independent phosphorylation of this site
was observed in neurons and in certain cancer cell lines; this
phosphorylation was shown to be due to Cdk5, a widely dis-
tributed proline-directed kinase with a substrate speciﬁcity similar
to Cdk1 (Kato and Maeda, 1999). Active Src is reported to be
irreversibly destroyed by Cullin-5-dependent ubiquitination and
proteosomal degradation (Hakak and Martin, 1999; Laszlo and
Cooper, 2009). More recently, it was shown that phosphoryla-
tion at Ser75 promotes the ubiquitin-dependent degradation of
Src (Pan et al., 2011). Ser75-Src phosphorylation in epithelial cells
was found to depend on the activation state of Src: only active Src
was phosphorylated and eventually marked for ubiquitination.
Thus, Cdk5-dependent phosphorylation of Ser75 within the UD
of Src represents a mechanism to restrict the availability of active
Src (Pan et al., 2011). Sequence alignment suggests that serine
residues are present in homologous positions of Yes and possibly
Frk.
NMR and mass-spectrometry studies of human Src UD added
to X. laevis egg extracts showed the phosphorylation of Ser75
and Ser69, as well as Ser 17 (Pérez et al., 2013). Phosphory-
lation of Ser75 and Ser69 seem to be mutually interfering in
vitro. Interestingly, X. laevis Src has a glycine residue at position
69 and phosphorylation of Ser69 in human Src had only been
previously detected by mass spectrometry in extracts of cancer
lines HCT116 and MDA-MB-435S (Oppermann et al., 2009). It is
tempting to speculate that pathological phosphorylation of Ser 69
in human cells could result in decreased phosphorylation of Ser75
and reduced degradation of active Src, leading to an oncogenic
phenotype caused by Src overactivation.
The interplay between various phosphorylation sites within
the UD emphasizes its role as a signaling integration hub.
Further input signals, in addition to phosphorylation, include
calcium-dependent interaction with calmodulin and the allosteric
interaction with Src SH3 domain (Pérez et al., 2013; Figure 2).
A further level of cross-talk between various phosphorylation
events was observed when the time-dependent phosphoryla-
tion of the UD was studied by real-time NMR in cell extracts
(Amata et al., 2013). In these experiments it was observed that
the activity of a PKA-like kinase, which phosphorylates Ser17,
also repressed the phosphatase(s) that catalyzed the dephospho-
rylation of Ser75. Thus, inhibition of PKA activity resulted in
dephosphorylation of both sites. Similarly, inhibition of Cdk
activity resulted in a reduction in the steady-state phosphoryla-
tion of both sites. On the other hand, addition of PKA caused
a robust phosphorylation of Ser75 by preventing the action of
the phosphatases that reverse the effect of Cdks. These results
show that the phosphorylation state of the UD of Src repre-
sents a sensor of the kinase-phosphatase network active at any
given moment in the cell. Experimental access to this informa-
tion is possible by using real-time NMR techniques (Selenko
et al., 2008; Theillet et al., 2012; Thongwichian and Selenko, 2012;
Amata et al., 2013). In contrast to folded domains, intrinsically
disordered domains, like the UD of Src, provide in vivo NMR
resolution comparable to that obtainable in vitro (Kosol et al.,
2013).
CONCLUDING REMARKS
The study of the UDs of SFKs, particularly that of Src, provides
an example of multilevel regulation through phosphorylation of
a membrane-bound intrinsically disordered domain. The occur-
rence of membrane tethering among IDRs is very common,
although its relevance is not always recognized. The results arising
from studies of UDs should stimulate further research to uncover
similar mechanisms beyond SFKs. In particular, switchable inter-
nal lipid binding sites (the ULBR in the case of Src) in disordered
domains anchored to membranes by a second, more stable, bind-
ing site close to the protein termini (the SH4 domain in the case of
SFKs) can modulate the position of the active domains (the kinase
or regulatory domains in the case of SFKs) with respect to the
membrane surface. Lipid binding by the internal site can switch
off the access of the active domains to target sites of membrane-
anchored substrates/partners located beyond a particular distance
from the membrane surface or, conversely, facilitate the inter-
action with sites near the membrane surface. Phosphorylation
or other modiﬁcations preventing the interaction of the internal
site would result in a release of the active domains, which can
then reach sites located further apart from the membrane surface
or disfavor the interaction with membrane-proximal sites. This
represents a new compartmentalization mechanism based on the
relative position of interacting sites with respect to the membrane
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surface. This mechanism enables modulating the functional inter-
actions between two proteins anchored next to each other in the
membrane.
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